The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

The decision comes only a week after it approved a new round of messenger RNA shots from Pfizer and Moderna, which both ...

Novavax NVAX announced that the FDA granted emergency use authorization (EUA) to an updated version of its protein-based ...

For many, Novavax is #1 – the one and only COVID vaccine they would consider. This enthusiasm for Novavax isn’t new. As far back as 2022, news reports described a kind of Novavax fan club – a term ...

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

Novavax, Inc. (NVAX) announced Friday that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The FDA granted Emergency Use Authorization to Novavax's updated COVID-19 vaccine for individuals aged 12 and older. The ...

Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a ...

The protein-based shot represents a non-mRNA option for the 2024-2025 season, and follows the agency's recent approvals and ...

Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know.

The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...